Gary Jacob’s rise to CEO of a Nasdaq-listed biotech company started with chemistry classes in Benton Hall and a willingness to take risks and embrace change.
LATEST IN Charles Armbruster
1969 alumnus’ journey to CEO of Synergy Pharmaceuticals, FDA-approved drug TRULANCE starts with UMSL chemistry degree
Gary Jacob’s rise to CEO of a Nasdaq-listed biotech company started with chemistry classes in Benton Hall and a willingness to take risks and embrace change.
1969 alumnus’ journey to CEO of Synergy Pharmaceuticals, FDA-approved drug TRULANCE starts with UMSL chemistry degree
Gary Jacob’s rise to CEO of a Nasdaq-listed biotech company started with chemistry classes in Benton Hall and a willingness to take risks and embrace change.
Eye on UMSL: An international welcome
UMSL Global team members kicked off Global Triton Welcome, a weeklong orientation to help new international students get acclimated ahead of the spring semester.
MORE IN Charles Armbruster
LATEST NEWS
- Eye on UMSL: An international welcome
- Nursing PhD graduate Cherryl Rainey researches the impact of mentorship on work engagement and professional development in nursing
- Third-year optometry student Hallie Traverse awarded scholarship from Wisconsin Optometric Association
- Education Assistant Professor Magen Rooney-Kron wins Early Career Research Award from TASH
- St. Louis County Council directing $10 million to UMSL’s planned North County Business and Workforce District
- Accounting alum Thomas Fabry has RubinBrown job lined up after CPA exam
- UMSL names George Nnanna founding director of new School of Engineering
- UMSL Tritons weekly rewind
- BSN graduate Madison Zerban working as a pediatric hematology and oncology nurse at St. Louis Children’s Hospital
- Eye on UMSL: Foundation for the future
